Multinational pharmaceutical firms such as Novartis, Sanofi, Pfizer, GlaxoSmithKline, etc, are on the brink of a decline in revenues due to patent expiry dates as many are losing the exclusive rights to produce some of their blockbuster drugs. This situation, industry experts believe, could lead to
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
